Article Versions Notes

Skotnicki M, Jadach B, Skotnicka A, Milanowski B, Tajber L, Pyda M, Kujawski J. Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy. Pharmaceutics. 2021; 13(1):118. https://doi.org/10.3390/pharmaceutics13010118

Skotnicki, Marcin, Barbara Jadach, Agnieszka Skotnicka, Bartłomiej Milanowski, Lidia Tajber, Marek Pyda, and Jacek Kujawski. 2021. "Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy" Pharmaceutics 13, no. 1: 118. https://doi.org/10.3390/pharmaceutics13010118

Skotnicki, M., Jadach, B., Skotnicka, A., Milanowski, B., Tajber, L., Pyda, M., & Kujawski, J. (2021). Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy. Pharmaceutics, 13(1), 118. https://doi.org/10.3390/pharmaceutics13010118